Pliant Therapeutics, Inc.PLRXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank75
3Y CAGR+3.8%
5Y CAGR+12.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+3.8%/yr
vs +45.1%/yr prior
5Y CAGR
+12.9%/yr
Recent deceleration
Acceleration
-41.3pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $153.06M | -33.0% |
| 2024 | $228.37M | +23.0% |
| 2023 | $185.72M | +35.7% |
| 2022 | $136.88M | +30.2% |
| 2021 | $105.11M | +25.9% |
| 2020 | $83.46M | +43.2% |
| 2019 | $58.28M | +88.5% |
| 2018 | $30.91M | +68.5% |
| 2017 | $18.35M | - |